218 related articles for article (PubMed ID: 34191582)
1. Novel Host Recognition Mechanism of the K1 Capsule-Specific Phage of
Gong Q; Wang X; Huang H; Sun Y; Qian X; Xue F; Ren J; Dai J; Tang F
J Virol; 2021 Aug; 95(18):e0092021. PubMed ID: 34191582
[TBL] [Abstract][Full Text] [Related]
2. Escherichia coli K1's capsule is a barrier to bacteriophage T7.
Scholl D; Adhya S; Merril C
Appl Environ Microbiol; 2005 Aug; 71(8):4872-4. PubMed ID: 16085886
[TBL] [Abstract][Full Text] [Related]
3. LamB, OmpC, and the Core Lipopolysaccharide of Escherichia coli K-12 Function as Receptors of Bacteriophage Bp7.
Chen P; Sun H; Ren H; Liu W; Li G; Zhang C
J Virol; 2020 Jun; 94(12):. PubMed ID: 32238583
[TBL] [Abstract][Full Text] [Related]
4. Escherichia coli K1-specific bacteriophage CUS-3 distribution and function in phase-variable capsular polysialic acid O acetylation.
King MR; Vimr RP; Steenbergen SM; Spanjaard L; Plunkett G; Blattner FR; Vimr ER
J Bacteriol; 2007 Sep; 189(17):6447-56. PubMed ID: 17601779
[TBL] [Abstract][Full Text] [Related]
5. Bacteriophage K1-5 encodes two different tail fiber proteins, allowing it to infect and replicate on both K1 and K5 strains of Escherichia coli.
Scholl D; Rogers S; Adhya S; Merril CR
J Virol; 2001 Mar; 75(6):2509-15. PubMed ID: 11222673
[TBL] [Abstract][Full Text] [Related]
6. Effects of lipopolysaccharide biosynthesis mutations on K1 polysaccharide association with the Escherichia coli cell surface.
Jiménez N; Senchenkova SN; Knirel YA; Pieretti G; Corsaro MM; Aquilini E; Regué M; Merino S; Tomás JM
J Bacteriol; 2012 Jul; 194(13):3356-67. PubMed ID: 22522903
[TBL] [Abstract][Full Text] [Related]
7. Genome-Wide Discovery of Genes Required for Capsule Production by Uropathogenic
Goh KGK; Phan MD; Forde BM; Chong TM; Yin WF; Chan KG; Ulett GC; Sweet MJ; Beatson SA; Schembri MA
mBio; 2017 Oct; 8(5):. PubMed ID: 29066548
[TBL] [Abstract][Full Text] [Related]
8. Differential activities of bacteriophage depolymerase on bacterial polysaccharide: binding is essential but degradation is inhibitory in phage infection of K1-defective Escherichia coli.
Pelkonen S; Aalto J; Finne J
J Bacteriol; 1992 Dec; 174(23):7757-61. PubMed ID: 1447142
[TBL] [Abstract][Full Text] [Related]
9. Selective synthesis and labeling of the polysialic acid capsule in Escherichia coli K1 strains with mutations in nanA and neuB.
Vimr ER
J Bacteriol; 1992 Oct; 174(19):6191-7. PubMed ID: 1400168
[TBL] [Abstract][Full Text] [Related]
10. The structures of bacteriophages K1E and K1-5 explain processive degradation of polysaccharide capsules and evolution of new host specificities.
Leiman PG; Battisti AJ; Bowman VD; Stummeyer K; Mühlenhoff M; Gerardy-Schahn R; Scholl D; Molineux IJ
J Mol Biol; 2007 Aug; 371(3):836-49. PubMed ID: 17585937
[TBL] [Abstract][Full Text] [Related]
11. The importance of the K1 capsule in invasive infections caused by Escherichia coli.
Cross AS; Gemski P; Sadoff JC; Orskov F; Orskov I
J Infect Dis; 1984 Feb; 149(2):184-93. PubMed ID: 6199436
[TBL] [Abstract][Full Text] [Related]
12. Formation of the K30 (group I) capsule in Escherichia coli O9:K30 does not require attachment to lipopolysaccharide lipid A-core.
MacLachlan PR; Keenleyside WJ; Dodgson C; Whitfield C
J Bacteriol; 1993 Dec; 175(23):7515-22. PubMed ID: 8244920
[TBL] [Abstract][Full Text] [Related]
13. The K1 capsule modulates trafficking of E. coli-containing vacuoles and enhances intracellular bacterial survival in human brain microvascular endothelial cells.
Kim KJ; Elliott SJ; Di Cello F; Stins MF; Kim KS
Cell Microbiol; 2003 Apr; 5(4):245-52. PubMed ID: 12675682
[TBL] [Abstract][Full Text] [Related]
14. A tale of tails: Sialidase is key to success in a model of phage therapy against K1-capsulated Escherichia coli.
Bull JJ; Vimr ER; Molineux IJ
Virology; 2010 Mar; 398(1):79-86. PubMed ID: 20006993
[TBL] [Abstract][Full Text] [Related]
15. In vivo growth rates are poorly correlated with phage therapy success in a mouse infection model.
Bull JJ; Otto G; Molineux IJ
Antimicrob Agents Chemother; 2012 Feb; 56(2):949-54. PubMed ID: 22106213
[TBL] [Abstract][Full Text] [Related]
16. The genome of bacteriophage K1F, a T7-like phage that has acquired the ability to replicate on K1 strains of Escherichia coli.
Scholl D; Merril C
J Bacteriol; 2005 Dec; 187(24):8499-503. PubMed ID: 16321955
[TBL] [Abstract][Full Text] [Related]
17. Coexpression of colanic acid and serotype-specific capsular polysaccharides in Escherichia coli strains with group II K antigens.
Keenleyside WJ; Bronner D; Jann K; Jann B; Whitfield C
J Bacteriol; 1993 Oct; 175(20):6725-30. PubMed ID: 8407850
[TBL] [Abstract][Full Text] [Related]
18. Extensive Diversity in Escherichia coli Group 3 Capsules Is Driven by Recombination and Plasmid Transfer from Multiple Species.
Hong Y; Qin J; Forga XB; Totsika M
Microbiol Spectr; 2023 Aug; 11(4):e0143223. PubMed ID: 37358457
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the K1 capsule biosynthesis genes of Escherichia coli: definition of three functional regions for capsule production.
Boulnois GJ; Roberts IS; Hodge R; Hardy KR; Jann KB; Timmis KN
Mol Gen Genet; 1987 Jun; 208(1-2):242-6. PubMed ID: 3302608
[TBL] [Abstract][Full Text] [Related]
20. Evolution of bacteriophages infecting encapsulated bacteria: lessons from Escherichia coli K1-specific phages.
Stummeyer K; Schwarzer D; Claus H; Vogel U; Gerardy-Schahn R; Mühlenhoff M
Mol Microbiol; 2006 Jun; 60(5):1123-35. PubMed ID: 16689790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
